(Q38935815)

7 September 2017

Role for chondroitin sulfate glycosaminoglycan in NEDD9-mediated breast cancer cell growth (English)

1 reference

7 September 2017

1 reference

Joji Iida

1

1 reference

7 September 2017

Jesse Dorchak

2

1 reference

7 September 2017

Rebecca Clancy

3

1 reference

7 September 2017

Juliana Slavik

4

1 reference

7 September 2017

Rachel Ellsworth

5

1 reference

7 September 2017

Yasuhiro Katagiri

6

1 reference

7 September 2017

Elena N Pugacheva

7

1 reference

7 September 2017

Toin H van Kuppevelt

8

1 reference

7 September 2017

Richard J Mural

9

1 reference

7 September 2017

Mary Lou Cutler

10

1 reference

7 September 2017

Craig D Shriver

11

1 reference

7 September 2017

language of work or name

English

0 references

publication date

13 November 2014

1 reference

Experimental Cell Research

7 September 2017

1 reference

7 September 2017

330

1 reference

7 September 2017

2

1 reference

7 September 2017

358-370

1 reference

Metastases: the glycan connection

7 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.11.002

Altered tumor-cell glycosylation promotes metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.11.002

Chondroitin sulfate-cell membrane effectors as regulators of growth factor-mediated vascular and cancer cell migration.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.11.002

Glycosylation-dependent lectin-receptor interactions preserve angiogenesis in anti-VEGF refractory tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.11.002

Extracellular matrix and cell signalling: the dynamic cooperation of integrin, proteoglycan and growth factor receptor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.11.002

Syndecans as modulators and potential pharmacological targets in cancer progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.11.002

Glypican-3 antibodies: a new therapeutic target for liver cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.11.002

Insidious changes in stromal matrix fuel cancer progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.11.002

Human genetic disorders caused by mutations in genes encoding biosynthetic enzymes for sulfated glycosaminoglycans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.11.002

Heparan sulfate proteoglycans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.11.002

Melanoma biomolecules: independently identified but functionally intertwined.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.11.002

Cell surface chondroitin sulfate proteoglycans in tumor cell adhesion, motility and invasion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.11.002

CSPG4 in cancer: multiple roles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.11.002

Potential therapeutic application of chondroitin sulfate/dermatan sulfate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.11.002

Melanoma chondroitin sulfate proteoglycan regulates matrix metalloproteinase-dependent human melanoma invasion into type I collagen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.11.002

Cell surface chondroitin sulfate glycosaminoglycan in melanoma: role in the activation of pro-MMP-2 (pro-gelatinase A).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.11.002

Additive benefits of chondroitin sulfate and oriented tethered epidermal growth factor for vascular smooth muscle cell survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.11.002

Interaction of chondroitin sulfate and dermatan sulfate from various biological sources with heparin-binding growth factors and cytokines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.11.002

A sulfated glycosaminoglycan array for molecular interactions between glycosaminoglycans and growth factors or anti-glycosaminoglycan antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.11.002

Biosynthesis and function of chondroitin sulfate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.11.002

Integrin signalling adaptors: not only figurants in the cancer story

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.11.002

Cas and NEDD9 Contribute to Tumor Progression through Dynamic Regulation of the Cytoskeleton

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.11.002

CAS proteins in normal and pathological cell growth control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.11.002

NEDD9 promotes oncogenic signaling in mammary tumor development.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.11.002

NEDD9 regulates actin dynamics through cortactin deacetylation in an AURKA/HDAC6-dependent manner.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.11.002

FH535 inhibited migration and growth of breast cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.11.002

Functions of chondroitin sulfate/dermatan sulfate chains in brain development. Critical roles of E and iE disaccharide units recognized by a single chain antibody GD3G7.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.11.002

Antibody GD3G7 selected against embryonic glycosaminoglycans defines chondroitin sulfate-E domains highly up-regulated in ovarian cancer and involved in vascular endothelial growth factor binding.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.11.002

Melanoma chondroitin sulphate proteoglycan regulates cell spreading through Cdc42, Ack-1 and p130cas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.11.002

Membrane type-1 matrix metalloproteinase promotes human melanoma invasion and growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.11.002

Gene expression differences in adipose tissue associated with breast tumorigenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.11.002

Molecular response of the axillary lymph node microenvironment to metastatic colonization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.11.002

NEDD9 regulates 3D migratory activity independent of the Rac1 morphology switch in glioma and neuroblastoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.11.002

NEDD9 promotes lung cancer metastasis through epithelial-mesenchymal transition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.11.002

Heparanase as a target in cancer therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.11.002

Contributions of chondroitin sulfate proteoglycans to neurodevelopment, injury, and cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.11.002

MINI REVIEW Keratan sulfate: structure, biosynthesis, and function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.11.002

4-methylumbelliferone leads to growth arrest and apoptosis in canine mammary tumor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.11.002

Therapeutic potential of hyaluronan oligosaccharides for bone metastasis of breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.11.002

Iduronic acid in chondroitin/dermatan sulfate affects directional migration of aortic smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.11.002

Serglycin is implicated in the promotion of aggressive phenotype of breast cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.11.002

Biological functions of iduronic acid in chondroitin/dermatan sulfate.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.11.002

Proteoglycans and their roles in brain cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.11.002

Involvement of highly sulfated chondroitin sulfate in the metastasis of the Lewis lung carcinoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.11.002

CD44 in hematological neoplasias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.11.002

Chondroitin sulfates play a major role in breast cancer metastasis: a role for CSPG4 and CHST11 gene expression in forming surface P-selectin ligands in aggressive breast cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.11.002

Understanding the dual nature of CD44 in breast cancer progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.11.002

Expression of N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase involved in chondroitin sulfate synthesis is responsible for pulmonary metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.11.002

Specific molecular interactions of oversulfated chondroitin sulfate E with various heparin-binding growth factors. Implications as a physiological binding partner in the brain and other tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.11.002

Versican interacts with chemokines and modulates cellular responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.11.002

Interstitial guidance of cancer invasion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.11.002

Deregulation of hyaluronan synthesis, degradation and binding promotes breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.11.002

4-Methylumbelliferone inhibits hyaluronan synthesis by depletion of cellular UDP-glucuronic acid and downregulation of hyaluronan synthase 2 and 3.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.11.002

Antisense-mediated suppression of hyaluronan synthase 2 inhibits the tumorigenesis and progression of breast cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.11.002

Silencing of hyaluronan synthase 2 suppresses the malignant phenotype of invasive breast cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.11.002

Tumorigenicity of virus-transformed cells in nude mice is correlated specifically with anchorage independent growth in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.11.002

The proliferative and migratory activities of breast cancer cells can be differentially regulated by heparan sulfates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.11.002

Differential roles for membrane-bound and soluble syndecan-1 (CD138) in breast cancer progression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.11.002

Mammosphere culture of metastatic breast cancer cells enriches for tumorigenic breast cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.11.002

Mammosphere formation in breast carcinoma cell lines depends upon expression of E-cadherin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.11.002

Chondroitin sulfate-E is a negative regulator of a pro-tumorigenic Wnt/beta-catenin-Collagen 1 axis in breast cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.11.002

Chondroitin sulfate is indispensable for pluripotency and differentiation of mouse embryonic stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.11.002

Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.11.002

Targeting breast cancer stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.11.002

Dynamic regulation of CD24 and the invasive, CD44posCD24neg phenotype in breast cancer cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.11.002

10.1016/J.YEXCR.2014.11.002

7 January 2021

Identifiers

DOI

1 reference

7 September 2017

1 reference